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Peter Štacko,*[a] and Petr Kl#n*[a]
Abstract: Carbon monoxide (CO) is an endogenous signal-
ing molecule that controls a number of physiological pro-
cesses. To circumvent the inherent toxicity of CO, light-acti-
vated CO-releasing molecules (photoCORMs) have emerged
as an alternative for its administration. However, their wider
application requires photoactivation using biologically
benign visible and near-infrared (NIR) light. In this work, a
strategy to access such photoCORMs by fusing two CO-re-
leasing flavonol moieties with a NIR-absorbing cyanine dye
is presented. These hybrids liberate two molecules of CO in
high chemical yields upon activation with NIR light up to
820 nm and exhibit excellent uncaging cross-sections, which
surpass the state-of-the-art by two orders of magnitude. Fur-
thermore, the biocompatibility and applicability of the
system in vitro and in vivo are demonstrated, and a mecha-
nism of CO release is proposed. It is hoped that this strategy
will stimulate the discovery of new classes of photoCORMs
and accelerate the translation of CO-based phototherapy
into practice.
Introduction
Use of light as a control stimulus offers unparalleled advantag-
es in terms of availability, adjustability, high spatial and tempo-
ral precision, high orthogonality towards biochemical systems,
and the minimization of waste products. The irradiation wave-
lengths applicable in living organisms are restricted by the ad-
verse effects of UV- and visible-light absorption and optical
scattering by endogenous chromophores, which limits the
depth of tissue penetration.[1, 2] Successful application of photo-
dynamic therapy (PDT) lends credibility to the use of light in
the near-infrared (NIR) range of 650–900 nm, known as the
phototherapeutic window, in clinical applications.[3]
Carbon monoxide (CO) has recently emerged as a promising
target for photodelivery, possessing remarkable therapeutic
potential.[4–7] It is a naturally occurring cell-signaling molecule
exhibiting strong cytoprotective, cardioprotective, anti-inflam-
matory, and anti-microbial effects at submicromolar concentra-
tions.[8] Taking advantage of an anti-Warburg effect,[9] cancer
cells and tumors exposed to CO are forced to switch to oxida-
tive metabolism, leading eventually to growth inhibition, cellu-
lar exhaustion, and death.[10] Moreover, the sensitivity of cancer
cells towards chemotherapeutics is significantly increased (up
to 1000-fold) upon exposure to CO while simultaneously pro-
tecting normal cell growth and viability. CO also exhibits
potent multifactorial inhibitory and anti-angiogenic effects on
cancer proliferation.[11, 12]
However, owing to its inherent toxicity and arduous admin-
istration of CO, many CO-releasing molecules (CORMs), primari-
ly based on transition metal-carbonyl complexes, have been
developed.[4, 13, 14] Generally, these CORMs rely on enzymes as
the release triggers or on a solvent-mediated ligand exchange
reaction in aqueous media, methods that exhibit poor spatial
and temporal control over the release profile.[15, 16] Furthermore,
the metal backbone left upon CO release from these metal-car-
bonyl complexes can lead to uncontrolled reactions with adja-
cent cells, resulting in their damage and a major barrier to in
vivo CORM applications.[6] Transition-metal-free light-triggered
CORMs (photoCORMs) have recently appeared with the prom-
ise of circumventing these challenges. Many organic mole-
cules, such as cyclopropenones,[17–19] 1,3-cyclobutadiones,[20] or
1,2-dioxolane-3,4-diones,[21] liberate CO upon irradiation with
biologically adverse UV light. Cyclic aromatic a-diketones[22]
(lmax = 468 nm) and a xanthene-based carboxylic acid
[23] (lmax =
488 nm) have been designed to undergo photochemical decar-
bonylation with visible light. Recently, a class of p-extended
flavonols 1 based on a naturally occurring flavone scaffold has
been shown to efficiently release CO upon irradiation at 400–
540 nm (Figure 1 a, left),[24–27] and the effects of liberated CO on
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Department of Chemistry and RECETOX, Faculty of Science
Masaryk University, Kamenice 5, 62500 Brno (Czech Republic)
E-mail : stacko@mail.muni.cz
klan@sci.muni.cz
[b] Dr. L. Muchov#, Prof. L. V&tek
Institute of Medical Biochemistry and Laboratory Diagnostics
General Faculty Hospital and 1st Faculty of Medicine
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the cells were unequivocally demonstrated.[28] Our recent
mechanistic investigation of this system revealed the existence
of three orthogonal pathways for the CO photorelease.[29]
meso-Carboxy BODIPY derivative 2 is currently the only organic
photoCORM operating at the edge of a phototherapeutic
window (lmax = 652 nm), but it suffers from a low uncaging
cross-section Femax (Figure 1 a, right).
[30]
Results and Discussion
After elucidating the mechanism of photochemical CO release
from flavonol 1,[29] we envisioned that fusing its analog 3 with
an established chromophore could serve as a general strategy
for designing new classes of photoCORMs, especially those ab-
sorbing in the NIR region (Figure 1 b). Heptamethine cyanine
(Cy7) chromophore 4 was chosen for its strong absorption in
the center of the phototherapeutic window, synthetic versatili-
ty, and its well-established role in contemporary chemistry,
biology, and medicine.[31–34] For instance, the most prominent
cyanine dye, indocyanine green, is FDA approved and currently
enrolled in hundreds of clinical trials despite being discovered
over 60 years ago.[35] The symmetric nature of cyanines also
allows the installation of two flavonol moieties in the molecule,
facilitating a potential release of two equivalents of CO (Fig-
ure 1 c). In addition, such a system exhibits high customization
potential for further applications owing to the presence of sev-
eral versatile structural elements. The N-substituents of the in-
dolenine heterocycles can be used to tune its solubility in
aqueous media or for bioconjugation of enzyme ligands and
antibodies,[36] whereas the C4’ position of the heptamethine
chain can be used to tune absorption spectra[37] or photostabil-
ity,[38] or to attach targeting residues.[39, 40] The phenyl substitu-
ent of the flavonol moiety is introduced at a late stage of the
synthesis, which allows for the installation of additional sub-
stituents. In this work, we present a strategy to access potent
NIR-absorbing photoCORMs by designing flavonol-cyanine hy-
brids 5 a and b (Figure 1 c), and we describe their photochemi-
cal behavior and demonstrate their biological applicability in in
vivo experiments.
We synthesized hybrid 5 a and its analog 5 b featuring trime-
thylammonium substituents to facilitate its solubility in aque-
ous media (Figure 1 c). We reasoned that the flavonol core
must be constructed prior to assembling the cyanine scaffold,
which is susceptible to strongly basic and oxidative conditions
required in the flavonol preparation. The synthesis of 5 a–b
was started by the construction of an indolenine core 7 from 6
and 3-methyl-2-butanone in 97 % yield (Scheme 1). The me-
thoxy group of 7 was removed with BBr3, and the resulting
phenolic group was acylated with acetyl chloride. Subsequent
Fries rearrangement of 9 with AlCl3 at 190 8C provided the de-
sired methylketone 10 in 80 % yield in a regioselective fashion,
presumably because of steric hindrance imposed by the dime-
thylmethylene substituent. Algar–Flynn–Oyamada reaction of
10 with benzaldehyde or 4-(dimethylamino)benzaldehyde in
the presence of H2O2 provided flavonols 11 a–b in 22 % and
38 % yields, respectively. Methylation with TfOMe or MeI afford-
ed the building blocks 12 a–b, which were subsequently con-
densed with commercially available enamine 13 (see the Sup-
porting Information) to access the final cyanine-flavonol hy-
brids 5 a–b in 55 % and 51 % yields, respectively.
UV/Vis absorption spectra of cyanine-flavonol hybrids 5 a–b
in methanol display an intense absorption band typical for the
heptamethine cyanine dyes with lmax = 791 and 793 nm, re-
spectively (Figure 2 a and Table 1).[37] The compounds also ex-
hibit emission at lem = 815 and 819 nm, respectively, with the
intensity comparable to that of indocyanine green (ICG). Com-
pound 5 b in methanol or DMSO at spectroscopic concentra-
tions was found stable at 4 8C for days.
Irradiation of 5 a–b (c&4 V 10@6 m) in methanol at 770
(&60 mW cm@2) or 820 nm (&14 mW cm@2) with commercial
LEDs was initially (&50 min) accompanied by a small hypso-
chromic shift (&3 nm) of the major absorption bands and a
decrease of their intensities, and concurrent disappearance of
the absorption bands at 343 and 422 nm (Figure 2 b and Fig-
ure S52 in the Supporting Information). Because the substitu-
Figure 1. (a) Flavonol-based 1 (left) and BODIPY-based 2 (right) photo-
CORMs. (b) The concept of fusing a flavonol photoCORM moiety and a hep-
tamethine cyanine dye into the conjugated system proposed in this work.
Structural elements suitable for further modifications are depicted. (c) Photo-
chemical release of CO from cyanine-flavonol hybrids 5 a–b prepared and
studied herein. Trimethylammonium groups installed in 5 b facilitate solubili-
ty in aqueous media. Counter anions are omitted for clarity.




tion of the aromatic cores of the cyanine heterocycles affects
the cyanine absorption maxima relatively insignificantly owing
to its weak interaction with the HOMO and LUMO of the cya-
nine chromophore, we hypothesized that this process corre-
sponds to the photochemical cleavage of the terminal flavonol
rings (see below). Upon extended irradiation, the disappear-
ance of the major absorption bands at approximately 790 nm
and the appearance of very weak bands at about 420 nm were
observed, which is attributed to the subsequent photooxida-
tion of the cyanine heptamethine chain with singlet oxygen
Scheme 1. Synthesis of the cyanine-flavonol hybrids 5 a–b. Reaction conditions: (i) 3-methyl-2-butanone, AcOH, 110 8C, 97 %; (ii) BBr3, CH2Cl2, 0 8C to rt, 95 %;
(iii) AcCl, Et3N, CH2Cl2, rt, 59 %; (iv) AlCl3, neat, 190 8C, 80 %; (v) NaOH, 30 % H2O2, MeOH, 0 8C. 11 a : 22 %. 11 b : 38 %; (vi) 12 a : MeOTf, CH2Cl2, 86 % or 12 b :
1) MeI, MeCN, 100 8C; 2) AgOTf, MeOH 81 %; (vii) enamine 13, AcONa, EtOH, reflux. 5 a : 55 %. 5 b : 51 %.
Figure 2. (a) UV/Vis absorption (solid) and emission (dotted) spectra of the hybrids 5 a (red) and 5 b (blue). (b) Irradiation of 5 b (c&3.8 V 10@6 m) at 820 nm in
aerated methanol followed by UV/Vis spectroscopy at 10 min intervals (from blue to red lines). The inset depicts a kinetic trace of the absorption at 793 nm
superimposed with the liberation of CO in time (black). (c) Total chemical yields of CO produced in the dark or upon exhaustive irradiation of 5 a (red) or 5 b
(blue) in methanol or PBS (pH 7.4, 10 mm, I = 100 mm) at 770 or 820 nm, respectively. The error bars represent the standard deviation of the mean from four
independent samples. (d) Time-dependent CO release from 5 b (c&4 V 10@6 m) ; blue line: irradiated at 770 nm in methanol; red line: irradiated at 820 nm in
methanol; black line: irradiated at 820 nm in PBS. The CO released to the headspace was determined by GC and is expressed as the total chemical yield.




produced by sensitization of the oxygen present in the solu-
tion (Figure S63 in the Supporting Information).[41] Self-sensi-
tized photooxygenation is known to be a primary photo-
bleaching pathway of cyanines and has recently been utilized
for NIR uncaging.[42, 43] These two distinct photochemical pro-
cesses were also clearly distinguished for 5 b from the kinetic
trace detected at 793 nm (Figure 2 b, inset). The phototransfor-
mation efficiency of 5 b in degassed methanol was severely
suppressed; only an approximately 20 % decrease in absorb-
ance at 793 nm was observed after irradiation for 16 h (Figur-
es S54 and S55 in the Supporting Information).
In the next step, we assessed whether the photolysis of 5 a–
b with NIR light is accompanied by the anticipated formation
of CO (Figure 2 c). Septum-sealed vials containing 5 a–b (c&4–
10 V 10@6 m) in methanol or phosphate-buffered saline (PBS,
pH 7.4, 10 mm, I = 100 mm) were irradiated or kept in the dark,
and the headspace above the solution was analyzed by using
gas chromatography. Indeed, exhaustive irradiation of 5 a–b in
methanol at 820 nm resulted in the formation of CO in (125:
15) % and (131:6) % chemical yields, respectively, whereas the
samples kept in the dark liberated only negligible (<2 %)
amounts of CO, demonstrating that the release is of photo-
chemical origin. The photolysis of water-soluble 5 b in PBS
(pH 7.4, 10 mm, I = 100 mm) at 770 or 820 nm generated CO in
(102:9) % and (110:6) % chemical yields, respectively, where-
as no CO was detected in the samples kept in the dark. Irradia-
tion of the parent cyanine 4 for 16 h did not lead to the pro-
duction of CO (<2 %). These results show that 5 a–b can re-
lease in principle two molecules of CO from both flavonol moi-
eties, corresponding to approximately 65 % and 55 % yields of
CO per flavonol unit in methanol and PBS, respectively. The
chemical yield values obtained in both methanol and aqueous
solutions are slightly lower than those observed for the parent
flavonol 1.[29] The majority of CO was released within 1–2 h of
irradiation (Figure 2 d) and is related to the first photochemical
process detected by UV/Vis spectroscopy (Figure S57 in the
Supporting Information). Under the given conditions, the ther-
apeutic levels of CO (1 mm,[44] corresponding to &25 % chemi-
cal yield) were reached after about 15 min of irradiation and
the total dose of light (&6.3 W cm@2) is comparable to doses
routinely used in PDT.[45] On the contrary, solutions of 5 b in de-
gassed methanol prepared under hypoxic conditions (
&3 ppm of O2 in the atmosphere) and irradiated at 770 nm
produced CO less efficiently (&30 %, &108 %, and &128 %
after 1, 24, and 36 h, respectively). This demonstrates the
pivotal role of oxygen in the photodecarbonylation process
but also indicates that the system can operate under the
hypoxic conditions often found in tumors, albeit with lower
efficiency (Figure S62 in the Supporting Information). Per-
forming the photolyzes in minimum essential medium
(MEM) or the presence of bovine serum albumin (BSA,
20 mg mL@1) did not influence the chemical yield of the re-
leased CO. Irradiation of 5 b in aerated methanol at 420 nm
produced CO in approximately 160 % chemical yield.
Subsequently, the efficiency of the NIR-light-triggered CO
photorelease was assessed. Owing to the lack of suitable ac-
tinometers operating in the NIR region, we instead opted to
use a calibrated Si-photodiode to measure the photon flux.
Coupling this with GC headspace analysis allowed us to direct-
ly determine the absolute quantum yields of CO release (FCO)
to be (2.0:0.3) V 10@4 and (3.0:0.5) V 10@4 for 5 a and 5 b in
aerated methanol, respectively (Table 1). The excellent uncag-
ing cross-section FCOemax of 5 a–b on the order of 50–
75 m@1 cm@1 is comparable to that of the parent flavonol 1
(&84 m@1 cm@1)[26] when operating at wavelengths batho-
chromically shifted by nearly 400 nm. The only transition-
metal-free photoCORM 2 activated by near-infrared light re-
ported to date possesses Femax of 0.6.
[30] Compared with this
value, the present system constitutes up to 110-fold increase
in the efficiency of the photochemical CO release with a simul-
taneous shift of the absorption maximum by approximately
140 nm to the NIR region. The strong absorption in the photo-
therapeutic window, high chemical yields of CO, and excellent
uncaging cross-section FCOemax showcase the practical utility
and applicability of the hybrids 5 a–b in biological settings.
The water-soluble derivative 5 b exhibited cytotoxic effects
in in vitro studies on the HepG2 hepatoblastoma cell line after
a 24 h exposure from concentrations as high as 100 mm (Fig-
ure S72 in the Supporting Information). We further probed the
cytotoxic effects of the photoproducts by exhaustive irradia-
tion of 5 b in the absence of HepG2 cells and subsequent ex-
posure of HepG2 cells to the mixture of photoproducts for
24 h (Figure S73 in the Supporting Information). This approach
enabled us to assess the effects of photoproducts independ-
ently from those of CO or 1O2. The photoproducts were found
to be non-toxic up to concentrations as high as 200 mm. Irradi-
ation of 5 b at 780 nm for 1 h incubated together with the
presence of HepG2 cells (Figure S74 in the Supporting Informa-
tion) had no significant effect on cell viability up to the con-
centration of 100 mm as measured 24 h post-irradiation, indi-
cating the low toxicity of the photoproducts. Encouraged by
these findings, we decided to evaluate the performance of 5 b
in in vivo experiments on nude SKH1 mice. Hairless mice were
used to facilitate light penetration through the cutaneous bar-
rier. One group of mice was not treated with 5 b, but received
vehicle only, and served as a control group. Another group re-
ceived an intraperitoneal injection of 5 b (50 mmol kg@1 of body
weight) in saline (10 mL g@1, with 5 % DMSO), and the mice
Table 1. Photophysical and photochemical properties of cyanine-flavonol

















5 a 791 815 25 4000 0.34:0.01 125:15 (2.0:0.3) V 10@2 51:8
5 b 793 819 25 1000 0.62:0.02 131:6 (3.0:0.5) V 10@2 75:12
All measurements were performed in methanol. [a] The molar absorption co-
efficient, emax. [b] The singlet oxygen production quantum yield was deter-
mined by using diphenylisobenzofurane (DPBF). Compounds 5 a and 5 b
were irradiated with 770 nm LEDs and ICG as a 1O2 generator (FD = 0.0077)
and used as a reference. [c] The total chemical yield of released CO, moni-
tored by GC headspace, obtained upon exhaustive irradiation at 770 nm.
[d] Absolute quantum yields of CO release at lmax determined by using a
calibrated Si-photodiode. [e] The CO uncaging cross-section at lmax : FCOemax.




were irradiated for 2 h with NIR light (lirr = 780 nm) focused on
the abdominal area. Irradiation resulted in a substantial in-
crease of carbonylhemoglobin (COHb) in the blood and of the
CO content in the liver and heart tissues when compared with
the control group (Figure 3). A significant increase in the CO
levels (up to 3-fold) in both the blood and tissues of the irradi-
ated mice demonstrates that the photorelease of CO from 5 b
also occurs in vivo.
We sought to provide additional support for the circumstan-
tial evidence obtained from Figure 2 b that the initial photode-
carbonylation process competes with a significantly less effi-
cient photooxidation of the Cy7 scaffold. Thus, the production
of singlet oxygen by sensitization of 5 a–b and the reactivity of
the individual molecular fragments towards oxygenation were
examined. The quantum yields of singlet oxygen formation
(FD) in methanol were found to be (3.4:0.1) V 10@3 and (6.2:
0.2) V 10@3, respectively, values which are comparable to those
of analogous cyanines and lower than those of FDA-approved
ICG.[46] The extended flavonol 1, which was previously utilized
in several biological studies, possesses FD of 14 %. The ratio
FD/FCO, which can serve as a handle to assess how much sin-
glet oxygen molecule is generated per molecule of released
CO, is more favorable for 5 b than for 1 by a factor of 2. We as-
sumed that the generated singlet oxygen can either cleave the
flavonol units with the concurrent expulsion of CO[29] or under-
go addition to the polyene chain of cyanine to destroy the
chromophore.[41] In our previous study, a neutral form of the
parent flavonol 1 was shown to be relatively unreactive to-
wards singlet oxygen in methanol with a bimolecular rate con-
stant kr of 4.3 V 10
5 m@1 s@1.[29] The kr values for 1 as well as for
14 B (see below) are in good agreement with those reported
for analogous 3.[47] On the contrary, the parent Cy7 scaffold 4
was found to be more reactive by nearly two orders of magni-
tude with kr of 1.7 V 10
7 m@1 s@1, the same order of magnitude
as those for heptamethine cyanines.[48] Applying a steady-state
approximation for singlet oxygen as a reactive intermediate
and employing the quantum yields FCO and FD determined
herein, we found that the CO release quantum yield is about
two orders of magnitude higher than that of self-sensitized
polyene photooxygenation (see the Supporting Information).
This implies that singlet oxygen quenching by the solvent is a
dominant deactivation pathway at low concentrations of cya-
nine.
In our recent mechanistic study of parent flavonol 1, two or-
thogonal pathways of CO release were identified under aerobic
conditions (Scheme 2).[29] Both the triplet excited state of acid
1 A and ground state of base 1 B can undergo decarbonylation.
The former species reacts with ground-state oxygen (3O2, path-
way A), whereas the latter reacts with singlet oxygen (1O2,
pathway B). Both 5 a and 5 b exist as conjugate acids in DMSO,
evidenced by the signal of phenolic groups in their 1H NMR
spectra. In analogy to 1 (pKa&9.3), we also assume that 5 a–b
in methanol exist exclusively as the conjugate acid. HRMS anal-
ysis of the sample of 5 a in methanol (c&4 V 10@5 m) irradiated
at 820 nm for 2 h revealed the presence of the anticipated
photoproducts (15 and 16 ; Figures S63–S64 in the Supporting
Information), analogous to 1 (Scheme 2 a), arising from the ex-
pulsion of CO from either single or both terminal flavonol
units, respectively (Scheme 2 b). As expected, the ratio of the
15 and 16 concentrations varied with the time of irradiation,
and we found that the cleavable benzoate ester moiety in
these photoproducts is spontaneously liberated (17 and 18 ;
see the Supporting Information). The same thermal reactivity
of the ester was observed for the photoproducts of parent fla-
vonol 1.[29] A complex mixture of products is obtained upon
exhaustive irradiation owing to the photodegradation of the
cyanine scaffold (Figure S63 in the Supporting Information).
However, we were able to detect some of the species formed
by photooxidative cleavage of the cyanine scaffold at the C2-
C1’ and C2-C3’ positions (Figure S65 in the Supporting Infor-
mation), which is in excellent agreement with the extensive
work of Schnermann and co-workers.[41]
A detailed mechanistic study of 5 b in aqueous media was
complicated by its propensity to form aggregates. Hence, we
decided to use simplified flavonol 14 as a model compound
for this purpose. The pKa of the OH group in 14 in water was
determined to be pKa = 7.98, which is lower than that of the
parent flavonol 1 (pKa&9.3)[29] owing to the presence of an
electron-withdrawing group. Therefore, flavonol 14 exists as a
mixture of conjugate acid 14 A and base 14 B (&20 %) at
pH 7.4 in PBS, and therefore, both decarbonylation pathways
(Scheme 2 a) should be relevant. CO was released from 14 in
PBS (pH 7.4, 10 mm, I = 100 mm) upon irradiation at 400 nm in
81 % chemical yield and with a quantum yield of Fdec = 6.0 V
10@3. This value is consistent with that obtained for 1 in a
DMSO/PBS mixture (pH 7.4, 1:1) by Berreau and co-workers.[25]
Next, we estimated the efficiency of the photooxygenation of
flavonol anion 14 B by 1O2 from its kr (kr = 5.8 V 10
8 m@1 s@1), and
Figure 3. CO release from 5 b upon irradiation in vivo. A control group of
eight animals (only vehicle application) is depicted in blue. Another group
of six animals (red) received an intraperitoneal injection of 5 b (50 mmol kg@1
of body weight) in vehicle (saline 10 mL g@1, 5 % DMSO) and was irradiated
with 780 nm light focused on the abdominal area for 2 h. The amounts of
CO are expressed as the relative amounts of COHb in the total amount of
Hb in the blood (wCOHb in %; left ordinate) or in pmol mg
@1 of fresh organ
tissue (right ordinate). The horizontal lines represent the median, the boxes
show the interquartile range. A statistically significant increase of CO was
observed in the blood, liver, and heart tissues of the irradiated mice (* P
value ,0.05 vs. “control group”; n = 6).




the FD value obtained for 5 b under conditions identical to
those employed in the irradiation experiments with 5 b in PBS.
The estimated value (Fcalc = 3 V 10
@5) was found to be lower by
one order of magnitude than that of the Cy7 photobleaching
in PBS (Fdec&1.8 V 10@4), suggesting that the pathway involv-
ing 1O2 (pathway B) is ineffective for 5 b, as it cannot compete
with the destruction of the Cy7 chromophore. Furthermore,
the production of CO from 5 b in methanol or PBS by irradia-
tion at 820 nm was not suppressed in the presence of a large
excess of diphenylisobenzofurane (DPBF, 1500 equiv) or furfuryl
alcohol (5000 equiv), respectively, as singlet oxygen traps (Fig-
ures S59–S60 in the Supporting Information). Based on these
considerations and in analogy to the behavior of 1, we pro-
pose that the singlet oxygen decarbonylation pathway is ineffi-
cient for 5 a–b, and the photorelease of CO occurs predomi-
nantly through the reaction of their triplet excited states with
ground-state oxygen (pathway A) in concentrations that are
common in biological aqueous media under aerobic condi-
tions.
Conclusion
We have developed a new class of transition-metal-free photo-
CORMs by fusing an established CO-releasing flavonol moiety
with a NIR-absorbing cyanine chromophore. The resulting hy-
brids liberate CO in high chemical yields upon activation with
NIR light up to 820 nm and with excellent uncaging cross sec-
tions. Their photochemical performance, in vitro biocompatibil-
ity, minimal intrinsic phototoxicity as well as applicability in in
vivo experimental settings, promise many avenues for their
future applications. In a more general sense, we have shown
that this concept can serve as an inspiration for the discovery
of new types of photoCORMs, and we believe that it repre-
sents a crucial step towards light-activated targeted delivery of
CO for therapeutic purposes.
Experimental Section
Animal studies: Male nude SKH1 mice were used. All studies in this
work met the criteria for the care and use of animals and were ap-
proved by the Animal Research Committee of the 1st Faculty of
Medicine, Charles University, Prague.
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